Filter Results:
(14)
Show Results For
- All HBS Web (14)
- Faculty Publications (4)
Show Results For
- All HBS Web (14)
- Faculty Publications (4)
Page 1 of 14
Results
- 2024
- Working Paper
Coronary Artery Bypass Grafting—Impossible to Routine: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Fabio Villa
We describe how Coronary Artery Bypass Grafting (CABG, or more popularly, “bypass”) operations
revolutionized the treatment of coronary disease (that can produce fatal heart attacks and debilitating
angina). Specifically, we chronicle the: 1) development of the... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Fabio Villa. "Coronary Artery Bypass Grafting—Impossible to Routine: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-010, July 2019. (Revised May 2024.)
- March 2015 (Revised February 2022)
- Supplement
CV Ingenuity (B): Epilogue
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors?
The... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Strategy; Health Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (B): Epilogue." Harvard Business School Supplement 315-087, March 2015. (Revised February 2022.)
- Article
Time-driven Activity-based Costing of Multivessel Coronary Artery Bypass Grafting across National Boundaries to Identify Improvement Opportunities: Study Protocol
By: F. Erhun, B. Mistry, T. Platcheck, A. Milstein, V.G. Narayanan and R. S. Kaplan
Coronary artery bypass graft (CABG) surgery is a common treatment for coronary artery disease—a disease that affects over 10% of US adults and is a major cause of morbidity and mortality. In 2005, the mean cost for a CABG procedure among Medicare beneficiaries in the... View Details
Keywords: Activity Based Costing and Management; Health Disorders; Health Care and Treatment; United States; India
Erhun, F., B. Mistry, T. Platcheck, A. Milstein, V.G. Narayanan, and R. S. Kaplan. "Time-driven Activity-based Costing of Multivessel Coronary Artery Bypass Grafting across National Boundaries to Identify Improvement Opportunities: Study Protocol." BMJ Open 5, no. 8 (2015).
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- 09 May 2017
- First Look
New Research and Ideas, May 9
to dealers with whom they have the strongest ties, and more so during periods of market turmoil. Systemically important dealers exploit their connections at the expense of peripheral dealers as well as clients, charging higher markups... View Details
Keywords: Sean Silverthorne
- Web
Organize Care Around Medical Conditions - Institute For Strategy And Competitiveness
represents either an acute or chronic disease process that may require management by multiple clinicians representing different specialties and types of providers and support personnel. Care for a medical condition involves management of... View Details
- Web
ICHOM - Institute For Strategy And Competitiveness
Consortium for Health Outcomes Measurement (ICHOM) works with patients, leading providers, and registries to create a global standard for measuring results by medical condition, from prostate cancer to coronary artery disease. ICHOM... View Details
- 20 Dec 2010
- Research & Ideas
Panama Canal: Troubled History, Astounding Turnaround
relationship that many scholars have claimed could greatly improve governance in many third world nations: the United States ran the currency, provided aid, posted an official inside the Panamanian government, and operated one of the great commercial View Details
- 01 Mar 2005
- News
Better Care at Lower Cost
good example of disruptive innovation, Christensen noted. Before the development of balloon angioplasty, patients with coronary artery disease had to be seriously ill before getting open-heart bypass... View Details
- 01 Dec 2013
- News
To Market, to Market
Inhibitors of proteins that play an important role in cholesterol and fat metabolism, to be developed as potential therapeutics for the treatment of diseases such as metabolic syndrome, type 2 diabetes, coronary View Details
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
he said, patients had to be "almost dead" before they could be treated for coronary artery disease with open-heart bypass surgery. The surgery was only available at select academic medical centers... View Details
- 09 Mar 2009
- Research & Ideas
How to Revive Health-Care Innovation
effective solution. In the past, business model innovation was common in health care. When the technological enablers for the diagnosis and treatment of infectious diseases emerged, most patient care was transferred away from hospitals to... View Details
- 13 Jun 2005
- Research & Ideas
From Turf Wars to Learning Curves: How Hospitals Adopt New Technology
hospitals. In the March 3, 2005, story Turf Wars in Coronary Revascularization, Pisano and Huckman looked at competing treatment methods for coronary artery disease and discovered a tough battleground... View Details